Published in Med J Aust on January 20, 1997
Evaluation of a national surveillance unit. Arch Dis Child (1999) 1.87
Rare disease surveillance: An international perspective. Paediatr Child Health (2001) 1.30
Why aren't all pregnant women being tested for HIV? Med J Aust (1997) 0.75
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat (2006) 5.10
Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet (1985) 3.33
Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS (1999) 3.28
Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet (1997) 2.97
Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology (2001) 2.90
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ (1998) 2.64
Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med (1996) 2.22
HIV disease progression in Australia in the time of combination antiretroviral therapies. Med J Aust (1998) 2.16
Java-based remote viewing and processing of nuclear medicine images: toward "the imaging department without walls". J Nucl Med (2000) 2.13
Trends in infectious disease mortality in Australia, 1979-1994. Med J Aust (1998) 2.02
Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ (1997) 1.92
Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs. Med J Aust (2000) 1.92
Evaluation of a national surveillance unit. Arch Dis Child (1999) 1.87
The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med J Aust (1999) 1.85
The role of initial AIDS-defining illness in survival following AIDS. AIDS (1995) 1.82
Acquired immunodeficiency without evidence of HIV infection: national retrospective survey. BMJ (1994) 1.78
Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer (1988) 1.74
Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS (2001) 1.72
Improving memory and control beliefs through cognitive restructuring and self-generated strategies. J Gerontol (1992) 1.69
Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost (1994) 1.63
Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study. Sex Transm Infect (2006) 1.59
Survival analyses of randomized clinical trials adjusted for patients who switch treatments. Stat Med (1996) 1.54
Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol (1997) 1.52
Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust (2000) 1.50
Risk of cancer in people with AIDS. AIDS (1999) 1.47
Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room. AIDS (1996) 1.46
Oral contraceptives and breast cancer: a national study. Br Med J (Clin Res Ed) (1986) 1.44
Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels. J Am Coll Cardiol (1997) 1.42
The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial. BJOG (2010) 1.42
Kawasaki disease in Australia, 1993-95. Arch Dis Child (1998) 1.42
Detection of HCV RNA in semen. Lancet (2000) 1.41
Premature mortality in Australia 1983-1992, the first decade of the AIDS epidemic. Med J Aust (1995) 1.40
Use of interventions for reducing mother-to-child transmission of HIV in Australia. Med J Aust (2001) 1.40
Humour in medical teaching. Med J Aust (2000) 1.40
Sexually transmissible diseases surveillance in Australia: towards a coordinated national system. Commun Dis Intell (1998) 1.40
Reporting of occupational exposures to blood-borne pathogens in Australian teaching hospitals. Med J Aust (1995) 1.38
Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer (1987) 1.37
Prior antiretroviral therapy experience protects against zidovudine-related anaemia. HIV Med (2007) 1.36
Heterogeneity of nephritic factor and its identification as an immunoglobulin. Proc Natl Acad Sci U S A (1977) 1.34
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis (2011) 1.32
A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee. Am J Public Health (1994) 1.32
A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest (1990) 1.32
Kaposi's sarcoma and protection from AIDS dementia complex. AIDS (1998) 1.30
Circumcision and male-to-male sexual transmission of HIV. AIDS (2001) 1.30
Properdin factor B and histocompatibility loci linked in the rhesus monkey. Nature (1975) 1.27
Elapid neurotoxins. Purification, characterization, and immunochemical studies of -bungarotoxin. Biochemistry (1972) 1.26
HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust (1997) 1.26
HIV and AIDS in the Asia-Pacific region: an epidemiological overview. AIDS (1998) 1.24
Water, electrolyte, glucose, and glycine absorption in rat small intestinal transplants. Gastroenterology (1988) 1.24
Predictors of recent HIV testing in homosexual men in Australia. HIV Med (2002) 1.23
Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. J Viral Hepat (2010) 1.23
The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev (1992) 1.23
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. J Viral Hepat (2007) 1.23
HIV surveillance in hard-to-reach populations. AIDS (2001) 1.22
B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS (2000) 1.20
Age-related response to lidocaine-prilocaine (EMLA) emulsion and effect of music distraction on the pain of intravenous cannulation. Pediatrics (1994) 1.19
Self-report is a valid measure of circumcision status in homosexual men. Sex Transm Infect (2008) 1.18
Immunogenetics of the Q and TL regions of the mouse. Crit Rev Immunol (1990) 1.18
Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br J Cancer (1987) 1.15
Rare childhood diseases: how should we respond? Arch Dis Child (2008) 1.14
Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4. Proc Natl Acad Sci U S A (2001) 1.13
Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency. J Clin Invest (1975) 1.11
A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med (1994) 1.09
HIV and tuberculosis in rural sub-Saharan Africa: a cohort study with two year follow-up. Trans R Soc Trop Med Hyg (1999) 1.09
Metabolism of properdin in normal subjects and patients with renal disease. J Clin Invest (1975) 1.09
Lifetime cost of human immunodeficiency virus-related health care. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.08
Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia. HIV Med (2009) 1.08
Health effects of the 1991 Kuwait oil fires: a survey of US army troops. J Occup Environ Med (1999) 1.06
Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Br J Cancer (2006) 1.06
The PHA dose-response curve: validation of the use of logarithmic graph paper by computer analysis results. J Immunol (1974) 1.05
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users. Epidemiol Infect (2006) 1.04
Hirschsprung's disease: the Australian Paediatric Surveillance Unit's experience. Pediatr Surg Int (2003) 1.03
Decay of transplacental human immunodeficiency virus type 1 antibodies in neonates and infants. J Infect Dis (1994) 1.02
HIV prevalence at reception into Australian prisons, 1991-1997. Med J Aust (1999) 1.01
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation. Health Technol Assess (2013) 1.01
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study. Drug Alcohol Depend (2010) 1.01
Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis (1993) 0.99
Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer. Br J Cancer (2001) 0.99
Secondary malignancies following cancer chemotherapy. Acta Oncol (1994) 0.99
Age-specific HIV incidence among homosexually active men in Australia. Med J Aust (1996) 0.98
The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFN gamma. Cancer Immunol Immunother (2001) 0.98
A case-control study of diet and breast cancer in Argentina. Int J Cancer (1989) 0.98
An investigation of the placebo effect and age-related factors in the report of needle pain from venipuncture in children. Pain (1997) 0.97
Adherence issues in children and adolescents receiving highly active antiretroviral therapy. AIDS Care (2003) 0.96
Fertility and reproductive choice in women with HIV-1 infection. AIDS (1997) 0.95
Birth prevalence of Prader-Willi syndrome in Australia. Arch Dis Child (2003) 0.95
Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis (1997) 0.94
Shiga toxin-producing Escherichia coli can impair T84 cell structure and function without inducing attaching/effacing lesions. Infect Immun (1999) 0.94
The usage and costs of health services for HIV infection in Australia. AIDS (1995) 0.94
Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group. AIDS Res Hum Retroviruses (1998) 0.94
Epidemiology of HIV and AIDS in the Asia-Pacific region. Med J Aust (1996) 0.93
Universal quantum viscosity in a unitary Fermi gas. Science (2010) 0.93
Intrinsic lymphocyte defect in Hodgkin's disease: analysis of the phytohemagglutinin dose-response. Clin Immunol Immunopathol (1975) 0.92
HIV infection in recipients of blood products from donors with known duration of infection. Lancet (1994) 0.92
Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia. HIV Med (2004) 0.92